Finding the Next Treatments for Autism and Other Neurological Disorders

Our Company Develops the Next Generation of Drug Efficacy Predictions for Autism and Other Neurological Disorders.

Using a Unique Combination of Technologies, We Created a Novel, Scalable, and Cost-Effective Platform for Diagnostics, and Drug Testing, Screening, and Discovery


Out of Children Under Age 10 in the United States is diagnosed with Autism


Out of the Children with ASD are Treated with Medications from Repurposing

200 Years

Of Medical Science and Still the Only Treatment Strategy is Trial and Error, and Retrospective Conclusions

We Have a Way to Test, Screen, and Develop Personalized Treatments for Neuro-Psychiatric Disorders with Predictions of Clinical Success

Our leadership

We Have a Team of Exceptional People with a Rich and Successful Record in Science, Technology, Entrepreneuring, and Business Management. Our R&D Team Comprises Talented Ph.D. Scientists with a Multidisciplinary Background, Including in the Fields of Drug Development, Neuroscience, Developmental Biology, Computer Science, Chemistry, and Physics.

Business Focus

Over 95% of the Pre-Clinically Developed Drugs Fail in the Translation to the Clinic, Causing Billions of Dollars in Losses for Pharma Companies. 

Our Technology Enables to Test, Screen, and Develop New Treatments for Autism and other Neurological Disorders with Significantly Higher Success Chances of Being Translated to the Clinic.

Together with Hadassah Hospital in Jerusalem, we are currently validating our drug discovery platform using samples of 200 patients

Skip to content